Nanocrystals for controlled delivery: state of the art and approved drug products-Reference-Cited by-同舟云学术

Nanocrystals for controlled delivery: state of the art and approved drug products

Published:2022-08-08 Issue:10 Volume:19 Page:1303-1316
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Kalhapure Rahul S.¹²,Palekar Siddhant³,Patel Ketan³,Monpara Jasmin⁴

Affiliation:

1. Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

2. Product Development, Odin Pharmaceuticals LLC, Somerset, NJ, USA

3. College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, USA

4. Department of Pharmaceutical Sciences, University of Sciences, Philadelphia, PA, USA

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2022.2110579

Reference68 articles.

1. DJF, U.S. Food and Drug Administration. Considering whether an FDA-regulated product involves the application of nanotechnology. Docket Number: FDA-2010-D-0530; 2014 June. [cited 2022 May 9]. Available from: http://www.fda.gov/RegulatoryInformation/Guidances/ucm257698.htm

2. Comparative assessment of nanomaterial definitions and safety evaluation considerations

3. Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of nanocrystals in pharmaceutical applications: A review of regulatory aspects and drug development process;Applied Materials Today;2024-10

2. Deferasirox nanosuspension loaded dissolving microneedles for ocular drug delivery;International Journal of Pharmaceutics;2024-10

3. Solubilization techniques used for poorly water-soluble drugs;Acta Pharmaceutica Sinica B;2024-09

4. Injectable long-acting formulations (ILAFs) and manufacturing techniques;Expert Opinion on Drug Delivery;2024-06-02

5. Fabrication and in vitro/vivo evaluation of quercetin nanocrystals stabilized by glycyrrhizic acid for liver targeted drug delivery;International Journal of Pharmaceutics: X;2024-06